These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29490363)

  • 1. Weighing the Risks and Benefits of Hormonal Contraception.
    Peachman RR
    JAMA; 2018 Mar; 319(11):1083-1084. PubMed ID: 29490363
    [No Abstract]   [Full Text] [Related]  

  • 2. Contemporary Hormonal Contraception and the Risk of Breast Cancer.
    Mørch LS; Skovlund CW; Hannaford PC; Iversen L; Fielding S; Lidegaard Ø
    N Engl J Med; 2017 Dec; 377(23):2228-2239. PubMed ID: 29211679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the Progestogen Used in Combined Hormonal Contraception Affect Venous Thrombosis Risk?
    Han L; Jensen JT
    Obstet Gynecol Clin North Am; 2015 Dec; 42(4):683-98. PubMed ID: 26598309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks of venous thromboembolism with various hormonal contraceptives.
    Allan GM; Koppula S
    Can Fam Physician; 2012 Oct; 58(10):1097. PubMed ID: 23064919
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer.
    Shapiro S
    Lancet Oncol; 2005 Oct; 6(10):736; author reply 737. PubMed ID: 16198976
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
    Grant EC
    J Natl Cancer Inst; 2011 Jul; 103(13):1069; reply 1069-70. PubMed ID: 21700925
    [No Abstract]   [Full Text] [Related]  

  • 7. [Contraconception in women with systemic lupus erythematosus].
    Cravioto Mdel C; Durand-Carbajal M; Sánchez-Guerrero J
    Rev Invest Clin; 2009; 61(2):150-9; discussion 159-60. PubMed ID: 19637729
    [No Abstract]   [Full Text] [Related]  

  • 8. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives.
    Shulman LP
    Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S9-13. PubMed ID: 21961825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current aspects of the oral hormonal contraception].
    Avramova V
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():49-59. PubMed ID: 19504710
    [No Abstract]   [Full Text] [Related]  

  • 10. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: progestin-only contraceptives.
    Burke AE
    Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S14-7. PubMed ID: 21961819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormonal contraceptives--an ongoing matter of research. Statement on the paper of C. Giersig: Progestin and breast cancer. The missing pieces of a puzzle].
    Löwer J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):779-81. PubMed ID: 18592337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormonal contraceptives].
    Carlotti N
    Rev Prat; 2008 Jan; 58(1):21-8. PubMed ID: 18326358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cancer of the breast. Influence of hormonal contraception].
    Gorins A
    Presse Med; 1984 May; 13(19):1207-10. PubMed ID: 6232568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Who is still afraid of the pill today? The development of hormonal contraception ('the pill') in the last 20 years. Current status].
    van Vliet M
    Tijdschr Ziekenverpl; 1982 Oct; 35(20):659-63. PubMed ID: 6923669
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hormonal contraceptives, peripheral venous insufficiency and the use of a phlebodynamic agent].
    Cervantes A; Gorodovsky J; Peña A; Campos J
    Ginecol Obstet Mex; 1976 Aug; 40(238):113-6. PubMed ID: 786800
    [No Abstract]   [Full Text] [Related]  

  • 16. Oestroprogestagens and severe acute pyelonephritis: a casual or causal association?
    Piccoli GB; Colla L; Mezza E; Burdese M; Cammarota T; Piccoli G
    Nephrol Dial Transplant; 2006 Aug; 21(8):2337. PubMed ID: 16868038
    [No Abstract]   [Full Text] [Related]  

  • 17. [The risk-benefit balance of estrogen-progestogen hormonal contraception].
    Plu-Bureau G; Raccah-Tebeka B
    Med Sci (Paris); 2022 Jan; 38(1):59-69. PubMed ID: 35060888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contraception: methods, contraindications, surveillance].
    Lopes P; Mensier A
    Rev Prat; 2000 Feb; 50(4):451-60. PubMed ID: 10748681
    [No Abstract]   [Full Text] [Related]  

  • 19. [Oral contraceptives: update].
    Fugère P
    Union Med Can; 1983 Feb; 112(2):109-12. PubMed ID: 6845551
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent advances in hormonal contraception.
    Erkkola R
    Curr Opin Obstet Gynecol; 2007 Dec; 19(6):547-53. PubMed ID: 18007132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.